1. Sybilski AJ, Raciborski F, Lipiec A, et al. Atopic dermatitis is a serious health problem in Poland. Epidemiology studies based on the ECAP study. Adv Dermatol Allergol 2015; 32(1): 1–10.
2.
Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care 2017; 23(8 Suppl.): S115–S123.
3.
Kowalska-Olędzka E, Czarnecka M, Baran A. Epidemiology of atopic dermatitis in Europe. J Drug Assess 2019; 8(1): 126–128.
4.
Boguniewicz M, Leung D. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242(1): 233–246.
5.
Fujii M. The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis. Cells 2021; 10(9): 2386.
6.
Bantz SK, Zhu Z, Zheng T. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol 2014; 5(2): 202.
7.
Steinke S, Beikert FC, Langenbruch A, et al. Measurement of healthcare quality in atopic dermatitis – development and application of a set of quality indicators. J Eur Acad Dermatol Venereol 2018; 32(12): 2237–2243.
8.
Camfferman D, Kennedy JD, Gold M, et al. Eczema and sleep and its relationship to daytime functioning in children. Sleep Med Rev 2010; 14(6): 359–369.
9.
Silverberg JI, Gelfand JM, Margolis DJ, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol 2019; 181(3): 554–565.
10.
Warschburger P, Buchholz HT, Petermann F. Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? Br J Dermatol 2004; 150(2): 304–311.
11.
Jiráková A, Vojáčková N, Göpfertová D, et al. A comparative study of the impairment of quality of life in Czech children with atopic dermatitis of different age groups and their families. Int J Dermatol 2012; 51(6): 688–692.
12.
Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants’ Dermatitis Quality of Life Index. Br J Dermatol 2001; 144(1): 104–110.
13.
Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132(6): 942–949.
14.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210–216.
15.
Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138(1): 107–113.
16.
Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018; 32(5): 657–682.
17.
Abuabara K, Ye M, McCulloch CE, et al. Clinical onset of atopic eczema: Results from 2 nationally representative British birth cohorts followed through midlife. J Allergy Clin Immunol 2019; 144(3): 710–719.
18.
Marciniak J, Reich A, Szepietowski JC. Quality of life of parents of children with atopic dermatitis. Acta Derm Venereol 2017; 97(6): 711–714.
19.
Kosse RC, Bouvy ML, Daanen M, et al. Adolescents’ Perspectives on Atopic Dermatitis Treatment-Experiences, Preferences, and Beliefs. JAMA Dermatol 2018; 154(7): 824–827.
20.
Nguyen CM, Koo J, Cordoro KM. Psychodermatologic Effects of Atopic Dermatitis and Acne: A Review on Self-Esteem and Identity. Pediatr Dermatol 2016; 33(2): 129–135.
21.
Andersen L, Nyeland ME, Nyberg F. Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A. Br J Dermatol 2020; 182(4): 1007–1016.
22.
Carroll CL, Balkrishnan R, Feldman SR, et al. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22(3): 192–199.
23.
Filanovsky MG, Pootongkam S, Tamburro JE, et al. The Financial and Emotional Impact of Atopic Dermatitis on Children and Their Families. J Pediatr 2016; 169: 284–290.
24.
Dodington SR, Basra MKA, Finlay AY, et al. The dermatitis family impact questionnaire: a review of its measurement properties and clinical application. Br J Dermatol 2013; 169(1): 31–46.
25.
Ring J, Zink A, Arents BWM, et al. Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults. J Eur Acad Dermatol Venereol 2019; 33(7): 1331–1340.
26.
Eyerich K, Gooderham MJ, Silvestre JF, et al. Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study. J Eur Acad Dermatol Venereol 2024; 38: 340–353.
27.
Ražnatović Ðurović M, Janković J, Ćirković A, et al. Impact of atopic dermatitis on the quality of life of children and their families. Ital J Dermatol Venerol 2021; 156(1): 29–35.
28.
Staab D, Diepgen TL, Fartasch M, et al. Age related, structured educational programs for the management of atopic dermatitis in children and adolescents: multicentre, randomized controlled trial. BMJ 2006; 332(7547): 933–938.
